<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="V pmcid: 7104151 S2211-0348(18)30358-4 doi: 10.1016/j.msard.2018.09.035 : Article Thymosins in" exact="multiple sclerosis" post="and its experimental models: moving from basic to clinical"/>
 <result pre="of Tβ4 in clinical practice. Keywords Multiple sclerosis Experimental autoimmune" exact="encephalomyelitis" post="Thymosin-β4 Thymosin-α1 Immunomodulation Neuroprotection Remyelination Abbreviations Abs, antibodies Breg,"/>
 <result pre="regulatory B cells CNS, central nervous system EAE, experimental autoimmune" exact="encephalomyelitis" post="HIV, human immunodeficiency virus IL, interleukin MBP, myelin basic"/>
 <result pre="oligodendrocytes OPCs, oligodendrocyte progenitor cells PLP, proteolipid protein peptide RA," exact="rheumatoid arthritis" post="RRMS, relapsing-remitting Multiple Sclerosis SLE, systemic lupus erythematosus Tα1,"/>
 <result pre="OPCs, oligodendrocyte progenitor cells PLP, proteolipid protein peptide RA, rheumatoid" exact="arthritis" post="RRMS, relapsing-remitting Multiple Sclerosis SLE, systemic lupus erythematosus Tα1,"/>
 <result pre="protein peptide RA, rheumatoid arthritis RRMS, relapsing-remitting Multiple Sclerosis SLE," exact="systemic lupus erythematosus" post="Tα1, thymosin-α1 Tβ4, thymosin-β4 TLR, toll-like receptor Treg, regulatory"/>
 <result pre="peptide RA, rheumatoid arthritis RRMS, relapsing-remitting Multiple Sclerosis SLE, systemic" exact="lupus erythematosus" post="Tα1, thymosin-α1 Tβ4, thymosin-β4 TLR, toll-like receptor Treg, regulatory"/>
 <result pre="disease of the central nervous system (CNS) displays a progressive" exact="neurodegeneration" post="due to immune attacks directly against myelin constituents that"/>
 <result pre="al., 1985) subjected to the model of MS experimental autoimmune" exact="encephalomyelitis" post="(EAE), the treatment showed no suppressive effect on incidence"/>
 <result pre="differently from that observed by other groups describing an intensive" exact="suppression" post="of EAE symptoms ( Nagai et al., 1982). Moreover,"/>
 <result pre="rat, mice, human motility, progression and metastatis of non-small cell" exact="lung cancer" post="( Banyard et al., 2007) Thymosins are divided into"/>
 <result pre="mice, human motility, progression and metastatis of non-small cell lung" exact="cancer" post="( Banyard et al., 2007) Thymosins are divided into"/>
 <result pre="and apoptosis, and ProTα was also found overexpressed in different" exact="cancer" post="types ( Mosoian, 2011). The extracellular ProTα shares many"/>
 <result pre="data, Tα1 was then used for the treatment of chronic" exact="hepatitis" post="B and C ( Iino et al., 2005, You"/>
 <result pre="2006), cytomegalovirus infection ( Bozza et al., 2007) and invasive" exact="aspergillosis" post="( Romani et al., 2004). In addition, the post-marketing"/>
 <result pre="confirmed Tα1 immunomodulatory activities and related therapeutic potential also in" exact="cancer" post="(such as Hepatocellular carcinoma, lung cancer, and melanoma), infectious"/>
 <result pre="related therapeutic potential also in cancer (such as Hepatocellular carcinoma," exact="lung cancer," post="and melanoma), infectious diseases (sepsis, infections after bone marrow"/>
 <result pre="found only up-regulated in different malignancies, such as the human" exact="prostate cancer," post="representing a potential biomarker ( Bao et al., 1996),"/>
 <result pre="Girardi et al., 2003, Sosne et al., 2007) via the" exact="suppression" post="of nuclear factor-kappa B (NF-kB) activation ( Sosne et"/>
 <result pre="white matter damage and result in neurological deficits, including stroke," exact="peripheral neuropathy" post="and traumatic brain injury, likewise show the benefits of"/>
 <result pre="matter damage and result in neurological deficits, including stroke, peripheral" exact="neuropathy" post="and traumatic brain injury, likewise show the benefits of"/>
 <result pre="( Morris et al., 2010). In a model of diabetes-induced" exact="peripheral neuropathy," post="extended Tβ4 treatment of diabetic mice significantly improved neurological"/>
 <result pre="et al., 2006). This characteristic was also recently tested in" exact="cystic fibrosis" post="where Tα1 increases the altered maturation of the cystic"/>
 <result pre="cystic fibrosis where Tα1 increases the altered maturation of the" exact="cystic fibrosis" post="transmembrane conductance regulator and reduces the chronic inflammation caused"/>
 <result pre="in patients affected with chronic inflammatory autoimmune diseases such as" exact="psoriatic arthritis," post="rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), that"/>
 <result pre="affected with chronic inflammatory autoimmune diseases such as psoriatic arthritis," exact="rheumatoid arthritis" post="(RA) and systemic lupus erythematosus (SLE), that have a"/>
 <result pre="with chronic inflammatory autoimmune diseases such as psoriatic arthritis, rheumatoid" exact="arthritis" post="(RA) and systemic lupus erythematosus (SLE), that have a"/>
 <result pre="autoimmune diseases such as psoriatic arthritis, rheumatoid arthritis (RA) and" exact="systemic lupus erythematosus" post="(SLE), that have a much lower level of serum"/>
 <result pre="diseases such as psoriatic arthritis, rheumatoid arthritis (RA) and systemic" exact="lupus erythematosus" post="(SLE), that have a much lower level of serum"/>
 <result pre="cell responses, MS was considered by far a T cell-mediated" exact="autoimmune disease." post="Nonetheless, over the past few years B cells have"/>
 <result pre="proved to be remarkably effective in the induction of long-lasting" exact="suppression" post="of lesion activity and clinical relapses but showed no"/>
 <result pre="Tα1. The clinical usage of Tα1 in the past in" exact="cancer" post="or chronic infections or as adjuvant in vaccine formulations"/>
 <result pre="of patients affected with chronic inflammatory autoimmune diseases such as" exact="psoriatic arthritis," post="RA and SLE ( Pica et al., 2016) as"/>
 <result pre="regimens of chemotherapeutics plus Tα1 adopted for treatment of many" exact="cancer" post="types ( Garaci et al., 2015), in MS a"/>
 <result pre="References References Ascherio A. Munger K.L. Environmental risk factors for" exact="multiple sclerosis." post="Part I: the role of infection. Ann. Neurol. 61"/>
 <result pre="299 17444504 Ascherio A. Munger K.L. Environmental risk factors for" exact="multiple sclerosis." post="Part II: noninfectious factors. Ann. Neurol. 61 6 2007"/>
 <result pre="a novel regulator of tumor cell motility upregulated in metastatic" exact="prostate cancer" post="Nat. Med. 2 12 1996 1322 1328 8946830 Bar-Or"/>
 <result pre="novel regulator of tumor cell motility upregulated in metastatic prostate" exact="cancer" post="Nat. Med. 2 12 1996 1322 1328 8946830 Bar-Or"/>
 <result pre="2010 452 461 20437580 Barun B. Bar-Or A. Treatment of" exact="multiple sclerosis" post="with anti-CD20 antibodies Clin. Immunol. 142 1 2012 31"/>
 <result pre="Prothymosin-alpha enhances HLA-DR antigen expression on monocytes from patients with" exact="multiple sclerosis" post="J. Neuroimmunol. 27 2-3 1990 141 147 2139665 Blair"/>
 <result pre="Development of thymosin beta4 for treatment of patients with ischemic" exact="heart disease" post="Ann. N. Y. Acad. Sci. 1112 2007 385 395"/>
 <result pre="memory and naive human B cell subsets and implication in" exact="multiple sclerosis" post="J. Immunol. 178 10 2007 6092 6099 17475834 Endoh"/>
 <result pre="T. Effect of thymic hormones on induction of experimental allergic" exact="encephalomyelitis" post="in old mice Tohoku J. Exp. Med. 161 4"/>
 <result pre="4 1996 511 525 8734446 Franciotta D. B cells and" exact="multiple sclerosis" post="Lancet Neurol. 7 9 2008 852 858 18703007 Garaci"/>
 <result pre="IFN-beta therapy modulates B-cell and monocyte crosstalk via TLR7 in" exact="multiple sclerosis" post="patients Eur. J. Immunol. 43 7 2013 1963 1972"/>
 <result pre="Thymosin-alpha1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting" exact="multiple sclerosis" post="patients Mult. Scler. 20171352458517695892 Girardi M. Anti-inflammatory effects in"/>
 <result pre="Habib J. Blood B cell and regulatory subset content in" exact="multiple sclerosis" post="patients J. Mult. Scler. (Foster City) 2 2 2015"/>
 <result pre="2015 Harlow D.E. Honce J.M. Miravalle A.A. Remyelination therapy in" exact="multiple sclerosis" post="Front. Neurol. 6 2015 257 26696956 Hoch K. Volk"/>
 <result pre="and safety of thymosin alpha-1 in Japanese patients with chronic" exact="hepatitis" post="B; results from a randomized clinical trial J. Viral"/>
 <result pre="Knippenberg S. Reduction in IL-10 producing B cells (Breg) in" exact="multiple sclerosis" post="is accompanied by a reduced naive/memory Breg ratio during"/>
 <result pre="555 564 27942867 Li R. Proinflammatory GM-CSF-producing B cells in" exact="multiple sclerosis" post="and B cell depletion therapy Sci. Transl. Med. 7"/>
 <result pre="injury J. Cell. Biochem. 2017 Liguori M. Proteomic profiling in" exact="multiple sclerosis" post="clinical courses reveals potential biomarkers of neurodegeneration PLoS One"/>
 <result pre="profiling in multiple sclerosis clinical courses reveals potential biomarkers of" exact="neurodegeneration" post="PLoS One 9 8 2014e103984 Liu F. The efficacy"/>
 <result pre="16 2016 488 27633969 Liu X.S. MicroRNA-146a promotes oligodendrogenesis in" exact="stroke" post="Mol. Neurobiol. 2016 Lu L.F. Function of miR-146a in"/>
 <result pre="L. Unaltered regulatory B-cell frequency and function in patients with" exact="multiple sclerosis" post="Clin. Immunol. 155 2 2014 198 208 25267439 Mizoguchi"/>
 <result pre="improves functional neurological outcome in a rat model of embolic" exact="stroke" post="Neuroscience 169 2 2010 674 682 20627173 Mosoian A."/>
 <result pre="1199 1208 21806381 Nagai Y. Osanai T. Sakakibara K. Intensive" exact="suppression" post="of experimental allergic encephalomyelitis (EAE) by serum thymic factor"/>
 <result pre="Y. Osanai T. Sakakibara K. Intensive suppression of experimental allergic" exact="encephalomyelitis" post="(EAE) by serum thymic factor and therapeutic implication for"/>
 <result pre="encephalomyelitis (EAE) by serum thymic factor and therapeutic implication for" exact="multiple sclerosis" post="Jpn. J. Exp. Med. 52 4 1982 213 219"/>
 <result pre="R. In-situ characterization of mononuclear cell infiltrates in lesions of" exact="multiple sclerosis" post="Neuropathol. Appl. Neurobiol. 8 5 1982 403 411 6983662"/>
 <result pre="alpha on the autologous and allogeneic MLR in patients with" exact="multiple sclerosis." post="Clin. Exp. Immunol. 70 2 1987 336 344 2962790"/>
 <result pre="L. Thymosin alpha1 represents a potential potent single-molecule-based therapy for" exact="cystic fibrosis" post="Nat. Med. 23 5 2017 590 600 28394330 Samara"/>
 <result pre="M. Thymosin beta4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and" exact="suppression" post="of the Toll-like proinflammatory pathway J. Biol. Chem. 289"/>
 <result pre="germinal centers in the meninges of patients with secondary progressive" exact="multiple sclerosis" post="Brain Pathol. 14 2 2004 164 174 15193029 Serafino"/>
 <result pre="1270 2012 13 20 23050812 Sosne G. Thymosin beta 4" exact="suppression" post="of corneal NFkappaB: a potential anti-inflammatory pathway Exp. Eye"/>
 <result pre="beta10 research: differential expression, molecular mechanisms, and clinical implications in" exact="cancer" post="and other conditions Cancer Invest. 27 10 2009 1016"/>
 <result pre="26096077 Walsh M.J. Immunoglobulin G, A, and M–clonal restriction in" exact="multiple sclerosis" post="cerebrospinal fluid and serum–analysis by two-dimensional electrophoresis Clin. Immunol."/>
 <result pre="327 3921302 Wang L. Thymosin beta4 promotes the recovery of" exact="peripheral neuropathy" post="in type II diabetic mice Neurobiol. Dis. 48 3"/>
 <result pre="3921302 Wang L. Thymosin beta4 promotes the recovery of peripheral" exact="neuropathy" post="in type II diabetic mice Neurobiol. Dis. 48 3"/>
 <result pre="is independent of blood glucose level in mice with diabetic" exact="peripheral neuropathy" post="J. Diabetes Res. 2015 2015173656 Wirsching H.G. Thymosin beta4"/>
 <result pre="independent of blood glucose level in mice with diabetic peripheral" exact="neuropathy" post="J. Diabetes Res. 2015 2015173656 Wirsching H.G. Thymosin beta4"/>
 <result pre="Pt 2 2014 433 448 24355709 Wolf S.D. Experimental autoimmune" exact="encephalomyelitis" post="induction in genetically B cell-deficient mice J. Exp. Med."/>
 <result pre="2278 8976182 Woyciechowska J. Goldstein A.L. Driscoll B. Experimental allergic" exact="encephalomyelitis" post="in guinea pigs. Influence of thymosin fraction V on"/>
 <result pre="of thymosin alpha-1 and interferon alpha in treatment of chronic" exact="viral hepatitis" post="B: a randomized controlled study World J. Gastroenterol. 12"/>
 <result pre="thymosin alpha-1 and interferon alpha in treatment of chronic viral" exact="hepatitis" post="B: a randomized controlled study World J. Gastroenterol. 12"/>
 <result pre="recovery after thymosin beta4 treatment in mice with experimental auto" exact="encephalomyelitis" post="Neuroscience 164 4 2009 1887 1893 19782721 Zhang J."/>
 <result pre="of tumorigenesis and metastasis and a novel serum marker in" exact="breast cancer" post="Breast Cancer Res. 19 1 2017 15 28179017 Zhou"/>
 <result pre="tumorigenesis and metastasis and a novel serum marker in breast" exact="cancer" post="Breast Cancer Res. 19 1 2017 15 28179017 Zhou"/>
</results>
